Vapogenix Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Vapogenix General Information

Description

Developer of non-opioid medications designed to alleviate pain associated with venipuncture, venous cannulation, and minor dermatological procedures. The company's medications are based on formulated volatile anesthetics and used on hospitalized children prior to venous access procedures by dermatologists to prevent pain associated with both aesthetic and medical procedures, enabling healthcare companies to save time and stress in waiting for current products to work and improve the productivity of hospital staff and dermatology practices.

Contact Information

Website
www.vapogenix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6622 Richmond
  • Suite 890
  • Houston, TX 77057
  • United States
+1 (713)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 6622 Richmond
  • Suite 890
  • Houston, TX 77057
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vapogenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-May-2026 Completed Clinical Trials - Phase 2
9. Grant 11-Nov-2020 Completed Clinical Trials - Phase 2
8. Grant 10-Sep-2018 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series C) 11-Jan-2018 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series C) 08-Dec-2016 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series B) 23-Dec-2014 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 23-Dec-2013 Completed Clinical Trials - Phase 2
3. Grant 03-Jul-2013 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A) 25-Feb-2013 $3.3M $3.3M Completed Clinical Trials - Phase 2
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view Vapogenix’s complete valuation and funding history, request access »

Vapogenix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 2,289,003 $0.001000 6% $1.44 $1.44 1x $1.41 14.23%
To view Vapogenix’s complete cap table history, request access »

Vapogenix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-opioid medications designed to alleviate pain associated with venipuncture, venous cannulation, and min
Drug Discovery
Houston, TX
2 As of 2026

Plymouth, MN
 

Concord, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vapogenix Competitors (2)

One of Vapogenix’s 2 competitors is Frenelle Pharma, a Venture Capital-Backed company based in Plymouth, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Frenelle Pharma Venture Capital-Backed Plymouth, MN
Tremeau Pharmaceuticals Venture Capital-Backed Concord, MA
You’re viewing 2 of 2 competitors. Get the full list »

Vapogenix Patents

  • 43

    Total Documents Applications and Grants

  • Total Patents Families

  • 29

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Vapogenix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10071065-B2 Analgesic compositions Active 15-Mar-2013
US-10507189-B2 Analgesic compositions Active 15-Mar-2013
US-10688062-B2 Analgesic compositions Active 15-Mar-2013
US-11304913-B2 Analgesic compositions Active 15-Mar-2013
US-20200022928-A1 Analgesic compositions Active 15-Mar-2013 A61K31/08
To view Vapogenix’s complete patent history, request access »

Vapogenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vapogenix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Arthritis and Musculoskeletal Diseases Not-For-Profit Venture Capital
To view Vapogenix’s complete investors history, request access »

Ready to get started?

Request a free trial

Vapogenix FAQs

  • When was Vapogenix founded?

    Vapogenix was founded in 2006.

  • Where is Vapogenix headquartered?

    Vapogenix is headquartered in Houston, TX.

  • What is the size of Vapogenix?

    Vapogenix has 2 total employees.

  • What industry is Vapogenix in?

    Vapogenix’s primary industry is Drug Discovery.

  • Is Vapogenix a private or public company?

    Vapogenix is a Private company.

  • What is Vapogenix’s current revenue?

    The current revenue for Vapogenix is .

  • How much funding has Vapogenix raised over time?

    Vapogenix has raised $18.2M.

  • Who are Vapogenix’s investors?

    National Institutes of Arthritis and Musculoskeletal Diseases has invested in Vapogenix.

  • Who are Vapogenix’s competitors?

    Frenelle Pharma and Tremeau Pharmaceuticals are competitors of Vapogenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process